National Hospital, Abuja, Nigeria
Research
Knowledge, Awareness and Incidence of Adverse Events Following Immunization with Oxford-AstraZeneca COVID-19 Vaccine Among Healthcare Professionals in Tertiary Healthcare Institutions in the North Central Zone of Nigeria.
Author(s): Haroun Omeiza Isah, Esizaze Ozekhome Mike, Ogbadu Samuel, Tse Paul Tersoo, Ukoh Iko-ojo Samuel, Balwa Victor Evuka and Kanu Chibuzo Okezie*
Background: The Oxford-AstraZeneca COVID-19 vaccine was deployed in Nigeria on the 5th of March, 2021 with a goal of vaccinating 70% of the population by 2022. This goal is however being threatened by widespread vaccine hesitancy fueled by skepticism around vaccine safety. This study leverages on the clinical acumen of healthcare professionals to evaluate the occurrence of adverse events following immunization to the vaccine in tertiary hospitals in Nigeria.
Methods: It was a retrospective study conducted using a self-administered questionnaire from 25th May to 17th July 2021 in 4 tertiary hospitals across the north central zone of Nigeria. Participants were asked to report the type, intensity and duration of symptoms experienced following Oxford-AstraZeneca COVID-19 vaccine administration. Data was analyzed using SPSS version 22.0.
.. View More»
DOI:
10.35248/1840-4529.22.14.3 41
